The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features
CONCLUSION: Inactivation of INI1 may play a role in the pathogenesis of RCC-RF. Erlotinib is recommended in the management of patients with INI1-related RCC.PMID:34243015 | DOI:10.1016/j.tranon.2021.101175
Source: Translational Oncology - Category: Cancer & Oncology Authors: Yi-Wen Wang Hsiang-Lin Song Cheng-Yao Chiang Hong-Fang Song Hong-Yi Chang Chien-An Chu Yih-Lin Tuan Kun-Hao Tsai Yin-Chien Ou Nan-Haw Chow Yuh-Shyan Tsai Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Genetics | Kidney Cancer | Renal Cell Carcinoma | Tarceva